Neurolief
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
12 Giborei Israel St, Netanya, Central D...Phone Number
(844) 277-6548Website
www.neurolief.comRevenue
$6.8 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Neurolief
Neurolief is a medical technology company focused on developing noninvasive neuromodulation therapies for the treatment of neurological and mental health conditions. Its solutions combine wearable devices, digital therapeutics, and cloud-connected platforms to stimulate targeted brain pathways associated with mood and pain regulation. The company’s approach enables patients to receive therapy in home or clinical settings while allowing physicians to monitor progress and adjust treatment remotely. Observers view Neurolief as part of a growing movement in neurotechnology that emphasizes accessible, patient-centered care through innovative brain stimulation techniques designed to improve outcomes in conditions such as migraine and depression.Explore more
Neurolief Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Neurolief your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Neurolief
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Neurolief had a recent Job posting/layoffs
Earning: See what the market has to say on Neurolief recently announced quarterly report
Neurolief, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Neurolief has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Neurolief launches new products
Funding: Get notified immidiatlly once Neurolief has new funding data
Check out if Neurolief is spiking on competitors!
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Neurolief is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Neurolief is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Neurolief.
Neurolief financials insights
Gather financial insights about Neurolief, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2026
Unspecified
$6M
Neurolief Tech Stack
A closer look at the technologies used by Neurolief
Most Recent Scoops
Funding
Funding
New Hire
Executive Move
Executive Moves, New Hire
New Hire
Executive Move
New Hire
Executive Move
New Hire
Executive Move
Neurolief News & Media
BrainsWay Announces FDA Approval of Neurolief’s Proliv™Rx Neuromodulation System for Major Depressive Disorder (MDD)
BrainsWay’s strategic investment in Neurolief paved the way for the first and only FDA approved at-home neuromodulation device with Class III Premarket Approval labeling for MDD patients who failed one or more prior antidepressants BrainsWay’s strategic investment in Neurolief paved the way for the first and only FDA approved at-home neuromodulation device with Class III Premarket Approval labeling for MDD patients who failed one or more prior antidepressantsNeurolief Announces Publication of Groundbreaking MOOD Study Demonstrating Efficacy of Home or Clinic-Based Neuromodulation Therapy for Major Depressive Disorder
CORAL SPRINGS, Fla., Sept. 9, 2025 /PRNewswire/ -- Neurolief, a neurotechnology company, is proud to announce the publication of the MOOD study. This trial is the first pivotal multicenter randomized sham-controlled clinical trial evaluating the safety and efficacy of Proliv™Rx, for Major...Neurolief Prepares for Launch of its Proliv™Rx System for Major Depressive Disorder with Strategic Investment from BrainsWay
CORAL SPRINGS, Fla. and NETANYA, Israel, Aug. 21, 2025 /PRNewswire/ -- Neurolief, a pioneering brain stimulation company specializing in non-invasive neuromodulation therapies, today announced a strategic investment from BrainsWay Ltd. (NASDAQ & TASE: BWAY), a publicly-traded global...BrainsWay Targets Expansion of its Total Addressable Market through a Strategic Investment in Neuromodulation Systems Developer, Neurolief Ltd.
This investment marks BrainsWay’s entrance into the market for mental health therapies that can be administered outside of a clinic, including at home
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Neurolief
Sign Up For FreeTo access detailed company insights
Neurolief is a medical technology company focused on developing noninvasive neuromodulation therapies for the treatment of neurological and mental health conditions. Its solutions combine wearable devices, digital therapeutics, and cloud-connected platforms to stimulate targeted brain pathways associated with mood and pain regulation. The company’s... Read More
